Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001823 · ClinicalTrials.gov registry record
Evaluation for NCI Surgery Branch Clinical Research Protocols
A clinical trial of Lung Cancer and Colorectal Cancer, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT00001823: Recruiting study of Lung Cancer and Colorectal Cancer, sponsored by National Cancer Institute (NCI).
NCT00001823 is a study of Lung Cancer and Colorectal Cancer that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 7,000 participants, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001823, a study of Lung Cancer and Colorectal Cancer, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol. ...
Primary Outcome
Total number of patients who enroll on NCI Surgery Branch clinical research protocols
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 1999-07-11 |
What NCT00001823 shows while recruiting
NCT00001823 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 919-participant average among 409 other Lung Cancer trials with a reported enrollment target (662% higher).
The record links to 5 conditions, with Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00001823 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001823 about?
NCT00001823 is a clinical study titled "Evaluation for NCI Surgery Branch Clinical Research Protocols". Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This st...
What is the current status of trial NCT00001823?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 1999-07-11.
What conditions does trial NCT00001823 study?
This clinical trial studies the following conditions: Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, Synovial Cell Cancer.
Who is sponsoring clinical trial NCT00001823?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001823 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001823's enrollment target sits among peer trials
7,000 13th of 409 higher than 396 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI